"We think we’re going to have major breakthroughs in the next few years to better treat the symptoms and try to slow the progression of PD." ...

Parkinson’s disease is a debilitating neurodegenerative disorder that affects approximately 1.1 million Americans. It is ...

Dr. Melinda Cail from Primary Health Partners joins us in the KFOR Studios on Thursday afternoon to discuss Parkinson's disease.

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this complex disease will likely need multiple complementary treatments.

According to a study published in the international journal, the number of Parkinson's disease patients worldwide is expected ...

The Parkinson’s disease (PD) market across the seven major markets (7MM: the US, France, Germany, Italy, Spain, the UK, and ...

By Dennis Thompson HealthDay ReporterFRIDAY, Aug. 8, 2025 (HealthDay News) — Staying active might slow the brain changes associated with Parkinson’s disease, a new study says.

A team led by University of Pisa biologist Sara De Vincentiis used mini-brains grown in a lab to test a technique they're calling "nano-pulling", using tiny magnetic particles controlled by magnetic ...

Although this study’s results may not directly help physicians, the researchers said they can enhance clinical studies on Parkinson’s disease and its treatments.

While Parkinson’s itself isn’t considered fatal, people can die from complications of the disease, including lung problems as muscle weakness impedes the ability to cough and to swallow.

Richard Drury - Getty Images An estimated 1.1 million Americans are living with Parkinson’s disease (PD), making it the second most common neurodegenerative disease after Alzheimer’s.

An estimated 1.1 million Americans are living with Parkinson’s disease (PD), making it the second most common neurodegenerative disease after Alzheimer’s. “Parkinson’s is a disease in which neurons ...